Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of N-alkylamino-heterocylic compounds for the treatment of migraine

Use of N-alkylamino-heterocylic compounds for the treatment of migraine

US Patent 6635639 · Granted Oct 21, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Providing data collaboration via a distributed secure collaboration framework2025
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2025
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2024
(R)-2-[(2H-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2022
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2022
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain con2020
Fluorinated amide derivatives and their uses as therapeutic agents2020
Kinase inhibitors and method of treating cancer with same2019